- Novo Nordisk snaps up Inversago Pharma for up to $1B+ on the back of megablockbuster Wegovy sales Endpoints News
- Novo Nordisk to acquire obesity drug developer Inversago Reuters
- Novo Nordisk bets $1.1B on Canadian biotech buyout, adding an old approach to obesity pipeline FierceBiotech
- Novo Nordisk to acquire Inversago Pharma to develop new therapies for people living with obesity, diabetes and other serious metabolic diseases GlobeNewswire
- Novo acquires Inversago for up to $1 billion, spotlighting troubled weight loss approach STAT
- View Full Coverage on Google News
Read original article here